Search results
3.6 million Medicare recipients could qualify for Wegovy under new rule
United Press International via Yahoo News· 10 hours agoThe U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the...
Enrolling in Medicare | UCNet
UC Newsroom· 10 hours agoIf you’re like most people, when you turn 65 you will become eligible to enroll in Medicare, the federal program to provide older adults and those with disabilities or permanent ...
Wegovy could soon treat millions of Medicare patients
Quartz· 14 hours agoMillions of Americans could now be eligible for Medicare to cover their prescriptions of the popular...
3 big changes coming to Medicare in 2025—and what they’ll mean for you
Fortune via Yahoo Finance· 2 days agoThe advice for people looking to enroll in Medicare Part D plans in 2025: Review your choices...
3.6 million Medicare enrollees may now be eligible for Wegovy coverage
CNN via Yahoo News· 20 hours agoAbout 3.6 million Medicare enrollees may qualify for coverage for the anti-obesity drug Wegovy,...
Millions of Medicare recipients could gain access to weight-loss drug
Newsweek· 16 hours agoMillions of overweight or obese patients with heart conditions insured under Medicare could gain...
6 Medicare mistakes to avoid if you’re working past age 65
Bankrate via Yahoo Finance· 6 days agoHere’s how to avoid easy mistakes while navigating your new health insurance options. 1. Not taking...
CMS Changes Medicare Advantage and Part D Plans’ Agent/Broker/TPMO Compensation Landscape
The National Law Review· 3 days ago...the Social Security Act, the Secretary has a “statutory obligation to establish guidelines to...
Humana warns of tough times ahead for Medicare Advantage
WDRB 41 Louisville News· 15 hours agoHumana and other insurers have said the Medicare Advantage payments will not keep pace with rising...
3.6M Medicare patients could qualify for Wegovy coverage: report (NYSE:NVO)
Seeking Alpha· 14 hours agoAround 3.6M older Americans could now be eligible to have Novo Nordisk’s (NVO) weight-loss drug...